BMJ Best Practice

参考文献

关键文献

Ryan S. Medicines for migraine. Arch Dis Child Educ Pract Ed. 2007;92:ep50-ep55.

Eccleston C, Palermo TM, de C Williams AC, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2014;(5):CD003968.

Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;(4):CD005220.

参考文章

1.  Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808.

2.  Ryan S. Medicines for migraine. Arch Dis Child Educ Pract Ed. 2007;92:ep50-ep55.

3.  Goadsby PJ. To scan or not to scan in headache. BMJ. 2004;329:469-470.

4.  Migraine. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 16th ed. Philadelphia, PA: Saunders; 2000:1832-1834.

5.  Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991 Nov 15;134(10):1111-20.

6.  Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA. 1992;267:64-69.

7.  Mortimer MJ, Kay J, Gawkrodger DJ, et al. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache. 1993;33:427-431.

8.  Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319-328.

9.  Bille B. Migraine in schoolchildren. Acta Paediatr Suppl. 1962;136:1-151.

10.  Deubner DC. An epidemiologic study of migraine and headache in 10-20 year olds. Headache. 1977;17:173-180.

11.  Evers S. Drug treatment of migraine in children. A comparative review. Paediatr Drugs 1999;1:7-18.

12.  Linet MS, Stewart WF, Celentano DD, et al. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211-2216.

13.  Barnes N, Millman G, James E. Migraine headache in children. Clin Evid. 2006;15:469-475.

14.  Bussone G. Pathophysiology of migraine. Neurol Sci. 2004;25 Suppl 3:S239-S241.

15.  Ferrari MD. Migraine. Lancet. 1998;351;1043-1051.

16.  Stewart WF, Staffa J, Lipton RB, et al. Familial risk of migraine: a population-based study. Ann Neurol. 1997 Feb;41(2):166-72.

17.  Rothner AD. Childhood migraine: clinical features, classifications and diagnostic criteria. In: Abu-Arefeh I, ed. Childhood headache. London: MacKeith Press; 2002:54-65.

18.  Hamalainen ML. Medical and dietary management of headache and migraine. In: Abu-Arefeh I, ed. Childhood headache. London: MacKeith Press; 2002:136-48.

19.  Passchier J, Orlebeke JF. Headaches and stress in schoolchildren: an epidemiological study. Cephalalgia. 1985 Sep;5(3):167-76.

20.  Amery WK, Vandenbergh V. What can precipitating factors teach us about the pathogenesis of migraine? Headache. 1987 Mar;27(3):146-50.

21.  Barnes NP, Jayawant S. Migraine. Arch Dis Child Educ Pract Ed. 2005;90:ep53-ep57.

22.  Wilne S, Koller K, Collier J, et al. The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour. Arch Dis Child. 2010 Jul;95(7):534-9.

23.  Bonfert M, Straube A, Schroeder AS, et al. Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache. Neuropediatrics. 2013 Feb;44(1):3-19.

24.  Eccleston C, Palermo TM, de C Williams AC, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2014;(5):CD003968.

25.  Bruijn J, Locher H, Passchier J, et al. Psychopathology in children and adolescents with migraine in clinical studies: a systematic review. Pediatrics. 2010 Aug;126(2):323-32.

26.  Silver S, Gano D, Gerretsen P. Acute treatment of paediatric migraine: a meta-analysis of efficacy. J Paediatr Child Health. 2008 Jan;44(1-2):3-9.

27.  Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;(4):CD005220.

28.  US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. April 2017 [internet publication].

29.  Medicines and Healthcare Products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. 2013 June;6(11):S1.

30.  European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication].

31.  Brenner M, Lewis D. The treatment of migraine headaches in children and adolescents. J Pediatr Pharmacol Ther. 2008 Jan;13(1):17-24.

32.  Damen L, Bruijn JK, Verhagen AP, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005 Aug;116(2):e295-302.

33.  Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010 Dec 1;12(6):379-89.

34.  Lewis DW, Winner P, Hershey AD, et al; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007 Aug;120(2):390-6.

35.  Winner P, Lewis D, Visser WH, et al; Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002 Jan;42(1):49-55.

36.  Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008 May;24(5):321-30.

37.  Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012 Jul;32(10):750-65.

38.  Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008 Oct;48(9):1326-36.

39.  Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. J Headache Pain. 2006 Apr;7(2):95-7.

40.  Berenson F, Vasconcellos E, Pakalnis A, et al. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache. 2010 May;50(5):795-807.

41.  Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012 Jun;129(6):e1411-20.

42.  Eiland LS, Jenkins LS, Durham SH. Pediatric migraine: pharmacologic agents for prophylaxis. Ann Pharmacother. 2007 Jul;41(7):1181-90.

43.  El-Chammas K, Keyes J, Thompson N, et al. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr. 2013 Mar 1;167(3):250-8.

44.  European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. EMA/145600/2018. March 2018 [internet publication].

45.  Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia. 1985;5(suppl 2):145-148.

46.  Sorge F, De Simone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia. 1988;8:1-6.

47.  Pearce JM. Migraine. In: Weatherall DJ, Ledingham JG, Warrell DA, eds. Oxford textbook of medicine. Oxford: Oxford University Press; 1996:4024-4026.

48.  McGrath PJ, Humphreys P, Keene D, et al. The efficacy of a self-administered treatment for adolescent migraine. Pain. 1992;49:321-324.

49.  Blau JN, Thavapalan M. Preventing migraine: a study of precipitating factors. Headache. 1988;28:481-483.

使用此内容应接受我们的免责声明